International Biotechnology Trust PLC Ascendis Pharma A/S Transaction History

International Biotechnology Trust PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$84.03 - $110.23 $2.24 Million - $2.94 Million	26,667 Added 975.74%	29,400 $3.04 Million
Q2 2022 Aug 16, 2022	SELL	$78.08 - $117.61 $2.08 Million - $3.14 Million	-26,667 Reduced 90.7%	2,733 $29.4 Million
Q3 2021 Nov 12, 2021	BUY	$112.67 - $176.92 $1.76 Million - $2.76 Million	15,600 Added 113.04%	29,400 $4.69 Million
Q3 2019 Nov 14, 2019	SELL	$95.8 - $118.9 $1.15 Million - $1.43 Million	-12,000 Reduced 46.51%	13,800 $1.33 Million
Q2 2019 Aug 14, 2019	BUY	$107.11 - $132.09 $1.29 Million - $1.59 Million	12,000 Added 86.96%	25,800 $2.97 Million
Q1 2019 May 14, 2019	BUY	$62.15 - $129.99 $857,670 - $1.79 Million	13,800 New	13,800 $1.62 Million

244

58.8M

250K

377K

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.61B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.